<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Nature Network - Recent topics from Breast cancer molecular subtypes</title>
    <description>The most recent forum topics from Breast cancer molecular subtypes</description>
    <link>http://network.nature.com/forum/breastcancersubtypes</link>
    <language>en-us</language>
    <ttl>40</ttl>
    <item>
      <title>How do I know if breast cancer information is reliable? (1 reply)</title>
      <description>
        <![CDATA[<p>How do I know if breast cancer information is reliable?</p>]]>
      </description>
      <pubDate>Mon, 18 Aug 2008 22:38:30 -0000</pubDate>
      <link>http://network.nature.com/forums/breastcancersubtypes/2231</link>
      <dc:creator>kennis john</dc:creator>
      <guid>http://network.nature.com/forums/breastcancersubtypes/2231</guid>
    </item>
    <item>
      <title>Cancer stem cells and breast cancer molecular subtypes (0 replies)</title>
      <description>
        <![CDATA[<p>A key paper published in 2003 by Al-Hajj et al. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12629218">link</a> prospectively identified and isolated tumor initiating cells (also called cancer stem cells) as <span class="caps">CD44</span>+CD24-/low Lin-neg from a series of plural effusions.  Many studies have since used these markers.  An unanswered question remains whether these markers identify tumor initiating cells, and whether a rare tumor initiating cell population exists, in all subtypes of breast cancer.  It has always been my thought that different subtypes of breast cancer would have tumor initiating cells identified by different markers.</p>


	<p>A recent paper was published in <span class="caps">PNAS</span>(Horwitz et al. 2008 <a href="http://www.pnas.org/cgi/content/abstract/105/15/5774">link</a>) showing a rare <span class="caps">CD44</span><ins>+ ER- PR- K5</ins>+ tumor initiating cell present in xenografts of <span class="caps">T47D</span>, a luminal subtype cancer cell line.  Therefore, maybe some human luminal tumors (perhaps luminal B)contain rare steroid negative tumorigenic cells which would be expected to be refractory to endocrine therapy and could survive and repopulate the tumor.</p>]]>
      </description>
      <pubDate>Thu, 03 Apr 2008 04:44:31 -0000</pubDate>
      <link>http://network.nature.com/forums/breastcancersubtypes/1304</link>
      <dc:creator>Jason Herschkowitz</dc:creator>
      <guid>http://network.nature.com/forums/breastcancersubtypes/1304</guid>
    </item>
    <item>
      <title>Basal-like vs Triple Negative:  are they the same? (0 replies)</title>
      <description>
        <![CDATA[<p>There have been recent questions about whether basal-like (defined by microarray) and triple negative (defined by <span class="caps">IHC</span> as ER, PR, and <span class="caps">HER</span> negative) are one and the same thing. Comments?</p>]]>
      </description>
      <pubDate>Thu, 27 Mar 2008 03:20:47 -0000</pubDate>
      <link>http://network.nature.com/forums/breastcancersubtypes/1271</link>
      <dc:creator>Jason Herschkowitz</dc:creator>
      <guid>http://network.nature.com/forums/breastcancersubtypes/1271</guid>
    </item>
  </channel>
</rss>
